FORM 10-Q

               SECURITIES AND EXCHANGE COMMISSION
                     Washington, D.C.  20549
(Mark One)
[ X ]     QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
                   SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 1997

                               OR

[   ]     TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
              OF THE SECURITIES EXCHANGE ACT OF 1934
For          the          transition         period          from
 .................to.................

Commission file number 33-19583

                    ZEVEX INTERNATIONAL, INC.
       (Exact name of registrant as specified in charter)

            NEVADA
87-0462807
(State or other jurisdiction of
(I.R.S. Employer
 incorporation or organization)
Identification No.)

5175 Greenpine Drive, Murray, Utah
84123
(Address of principal executive offices)
(Zip Code)

                         (801) 264-1001
      (Registrant's telephone number, including area code)

                                         Not Applicable
(Former name, former address, and former fiscal year, if changed since
last report)

Indicate by check mark whether the registrant (1) has filed all
reports required to be filed by section 13 or 15(d) of the Securities
Exchange Act of 1934 during the preceding 12 months (or for such
shorter period that the registrant was required to file such reports),
and (2) has been subject to such filing requirements for the past
90 days.  Yes  [ X ]    No

        APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY
           PROCEEDINGS DURING THE PRECEDING FIVE YEARS

Indicate by check mark whether the registrant has filed all documents
and reports required to be filed by Sections 12, 13 or 15(d) of the
Securities Exchange Act of 1934 subsequent to the distribution of
securities under a plan confirmed by a court.
Yes  [   ]    No  [   ]    Not Applicable  [ X ]
              APPLICABLE ONLY TO CORPORATE ISSUERS
Indicate the number of shares outstanding of each of the issuer's
classes of common stock, as of the latest practicable date.  As of May
8, 1997, the Company had outstanding 1,995,716 shares of common stock,
par value $0.04 per share.
                             PART I

                      FINANCIAL INFORMATION

______________________________________________________________________

       ITEM 1.  FINANCIAL STATEMENTS REQUIRED BY FORM 10-Q
______________________________________________________________________

ZEVEX International, Inc. (the "Company"), files herewith balance
sheets of the Company as of March 31, 1997, and December 31, 1996, and
the related statements of operations and cash flows for the respective
three month periods ended March 31, 1997 and 1996.  In the opinion of
management of the Company, the financial statements reflect all
adjustments, all of which are normal recurring adjustments, necessary
to fairly present the financial condition of the Company for the
interim periods presented.  The financial statements included in this
report on Form 10-Q should be read in conjunction with the audited
financial statements of the Company and the notes thereto included in
the annual report of the Company on Form 10-KSB for the year ended
December 31, 1996.
             ZEVEX INTERNATIONAL, INC. & SUBSIDIARY
                          Balance Sheet
                           -Unaudited-
                             ASSETS
                                       Mar 31             Dec 31
                                        1997              1996
CURRENT ASSETS
       Cash in Banks                 2,225,531           2,085,055
       Accounts Receivable           1,800,145           1,429,521
       Employee Advances                 5,076               5,350
       Tax Refunds                           0              41,458
       Work-In-Process               1,496,709           1,344,297
       Marketable Securities           203,109             203,109

     Total Current Assets            5,730,570           5,108,790
OTHER ASSETS
  Net Property & Equipment           2,344,504           1,207,034
  Patents and Trademarks                48,508              49,357
  Deposits                               3,489               3,489
Total Other Assets                   2,396,501           1,259,880
              TOTAL ASSETS           8,127,071           6,368,670

LIABILITIES & STOCKHOLDERS' EQUITY LIABILITIES
  Accounts Payable                     535,631             339,023
  Other Accrued Expenses               273,980             188,878
  Income Taxes Payable                  61,261                   0
  Bank Line of Credit                        0              60,108

  Total Current Liabilities            870,872             588,009

Long-Term Debt                       2,000,000           2,000,000
Deferred Taxes                          79,212              79,212
Total Long-Term Debt                 2,079,212           2,079,212

STOCKHOLDERS' EQUITY
 Common Stock 5,000,000 shares
 authorized at $0.04 par value
 issued and outstanding 1,495,716
 shares in 1995 and 1,995,716
 shares in 1996                        79,829              59,829
 Capital in Excess of Par Value     3,024,633           1,794,633
 Retained Earnings                  2,072,525           1,846,987
   Total Stockholders' Equity       5,176,987           3,701,449
TOTAL LIABILITIES &
STOCKHOLDERS' EQUITY                8,127,071           6,368,670




             ZEVEX INTERNATIONAL, INC. & SUBSIDIARY

                     Statement of Operations


                              For Three              For Three
                              Months Ended           Months Ended
                              3/31/96                3/31/97


REVENUES
Sales                         2,211,105                1,267,607
Cost of Sales                 1,172,675                  713,306

Gross Profit                  1,038,430                  554,301

General Expenses
 Marketing, G&A                 544,801                  357,218
 Research and Devel.            185,627                  114,228

Operating Income                308,002                   82,855

Other Income                     37,077                   13,084
Interest Expense            (   16,822)                        0

Provision for Taxes         (  102,719)                (  12,613)

Net Income (Loss)              225,538                     83,326

Income Per Share                 .1284                      .0610
Weighted Average
Shares Outstanding           1,756,827                   1,365,716




             ZEVEX INTERNATIONAL, INC. & SUBSIDIARY
                                
                     Statement of Cash Flows
                                
            For the three months ended March 31, 1997
                       and March 31, 1996
                                
                                   Mar 31              Mar 31
                                   1997                1996
Cash Flows from
Operating Activities:

Net income (loss)                225,538               83,326

Noncash revenue and 
expense adjustments:
   Depreciation                  82,209                46,860

Change in assets 
and liability accounts:
(Increase) decrease 
in accounts receivable        (370,624)               188,803
(Increase) decrease in 
work-in-process                (152,412)            (301,234)
(Increase) decrease in 
deposits                              0                 2,500
(Increase) decrease 
tax refunds                       41,458                    0
(Increase) decrease in 
employee advances                    274              (1,250)
Increase (decrease) in 
accounts payable                 196,608              170,564
Increase (decrease) in 
accrued expenses                  85,102               15,737
Increase (decrease) in 
provision for taxes               61,261              (35,489)
Increase (decrease) in 
bank line of credit             (60,108)                    0

Net Cash flows used for
   operating activities         109,306                169,817

Cash flows from investing activities:
   Purchase of 
   property & equipment     (1,218,830)               (189,473)

Cash flows from financing activities:
   Proceeds from issuance of 
   common stock              1,250,000                       0

Net increase (decrease) 
in cash                        140,476                ( 19,656)

Cash at 
beginning of period          2,085,055                 870,333

Cash at end of period        2,225,531                 850,677





            ZEVEX INTERNATIONAL, INC. AND SUBSIDIARY
                                
           NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                
                         March 31, 1997
                                
                                
1. Summary of Significant Accounting Policies

A. Business Information

     The Company was incorporated under the laws of the State of
     Nevada on December 30, 1987.  The Company was originally
     incorporated as Downey Industries, Inc. and changed its name
     to ZEVEX International, Inc. on August 15, 1988.

B. Principles of Consolidation

     The consolidated financial statements include the accounts of
     ZEVEX, International, Inc. (Company) and its wholly-owned
     subsidiary ZEVEX, Inc.  All significant inter company balances
     and transactions have been eliminated in the consolidation.
     
C. Machinery and Equipment

     Machinery and equipment are stated at cost less accumulated
     depreciation.  Depreciation is provided over expected useful
     lives of five or seven years on accelerated methods, which
     provide for more depreciation expense in the early years of the
     estimated life of the asset.
     
     Major replacements which extend the useful lives of equipment are
     capitalized and depreciated over the remaining useful life.
     Normal maintenance and repair items are charged to costs and
     expenses incurred.
     
     Upon retirement or disposal of property, plant or equipment, the
     costs and related accumulated depreciation amounts are eliminated
     and any gain or loss is included in operation in the year of
     disposition.
     
Notes to the financial statements - continued

D. Work In Process

     Work in process is stated at the lower of cost (first-in, first-
     out method) or market value.

E. Bad Debts

     The Company accounts for bad debts using the direct write off
     method.  Accounts are written off when deemed uncollectible.
     
F. Net Income Per Share

     The computation of net income per share of common stock is
     computed  by dividing net income for the period by the weighted
     average number of shares outstanding during the period.  Common
     stock equivalents which dilute earnings per share were not taken
     into consideration in the calculation because they had no
     material impact.

2. Business Combination

On August 11, 1988, the Company acquired the outstanding stock of
ZEVEX, Inc., a manufacturer and producer of acoustic and electronic
equipment for special applications, in exchange for 600,000 shares of
its common stock.  This business combination has been accounted for in
a manner similar to a pooling-of-interests.

     
3. Income Taxes

Provision for income taxes is made, at Federal and State statutory
rates, based on earnings reported in the financial statements for the
amount of income taxes payable currently, less any prepayment
deposits.  The provision for income taxes at March 31, 1997 and March
31, 1996 consists of the following:
                                             1997          1996

Federal income taxes                       $  51,952     $   7,816
State income taxes                             9,309         4,797
Provision for income tax                  $   61,261     $  12,613
==========    ==========

4. Major Customers

The Company distributes its products directly and is not dependent
upon any single customer.  However, sales to three customers for the
three months ending March 31, 1997, each represented 10% or more of
total sales.
______________________________________________________________________

        ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF
          FINANCIAL CONDITION AND RESULTS OF OPERATIONS
______________________________________________________________________

Results of Operations

The Company's sales increased to $2,211,105 in the first quarter of
1997 from $1,267,607 in the first quarter of 1996, an increase of
approximately 75% for the three months ending March 1997.  During the
first three months of 1996, 74% of total revenues resulted from sales
to three customers, all of whom were major customers in 1995.  Since
the Company's products are sold to OEMs as components for
incorporation into products manufactured by them, demand for the
Company's products is affected by the demand for the final products
manufactured by the OEMs, which is beyond the control of the Company,
and no assurances can be given that orders from any customer will
increase or remain at current levels or that they will not decline.

The Company's gross profit as a percentage of sales was 47% in the
first quarter of 1997, as compared to 43% in the first quarter of
1996. Management does not expect any significant changes in cost of
sales during 1997 with the product mix which is expected to be
delivered.

Selling, general and administrative expenses for the quarter ended
March 31, 1997 increased $187,583, from $357,218 in the first quarter
of 1996 to $544,801 in the first quarter of 1997.  Increased expenses
resulted from the Company's continuing expansion.  An increase in the
size of ZEVEX's physical facilities increased rental, utility and
related expenses incurred.  An expanded sales and marketing effort
increased staffing, travel, advertising and administrative expenses
related to the introduction of the EnteraLite(registered) feeding
pump.  The Company also had an increase in expenses related to
employees such as insurance, taxes and pension benefits.  The Company
believes that general and administrative expenses in 1997 as related
to sales will continue at approximately the same percentage as in the
previous two years.

Research and development expenses vary from quarter to quarter
depending on the number and nature of pending research and development
projects and their various stages of completion.  During the first
quarter of 1997 research and development expenses were $185,627
compared to $114,228 during the first quarter of 1996.  The expenses
incurred during the first quarter were for the continued development
of several proprietary products and new applications of the Company's
ultrasound technology.  In addition, the Company funded research and
development on behalf of its customers, in an effort to develop new
technologies and products in areas where there is a perceived demand.
Management believes investment in research and development will serve
the Company's future well, and will continue these expenses at the
current rate for at least the next several quarters.

Net income increased to $225,538, or 10.2% of net sales, in the first
quarter of 1997, from $83,326, or 6.6% of net sales, in the first
quarter of 1996.  The increase in net income percentage during 1997 as
compared to 1996 is principally due to the increase in sales and
related expenses for the current year.

As of March 31, 1997 the Company's backlog of customer orders was
$4,732,000, as compared to $2,808,000 on March 31, 1996.  Management
estimates that approximately 90% of the backlog will ship before
December 31, 1997.

Liquidity and Capital Resources

The Company generated net income of $308,002 from operations for
the first quarter of 1997.  As a result of increased expenditures
for inventories, accounts receivable, financing, and work in
progress for future sale, the Company used total cash of
$109,306.  Operating activities during the first quarter of 1996
created net cash of $169,817 on net income of $83,326.

The Company's purchases of facilities, new research, production,
testing equipment and tooling increased to $1,218,830 for the
first quarter of 1997, from $189,473 in 1996.  The Company paid
$1,129,892 toward its new manufacturing facility.  Total
expenditures for equipment of $88,938 were primarily due to
upgrading the Company's production fixturing, tooling and
research and engineering capabilities.  The Company expects to
spend approximately $240,000 in 1997 for additional manufacturing
equipment as well as for normal replacement of old equipment.
The Company also anticipates spending approximately $600,000 in
additional research and development expenses during 1997.  It is
estimated that overhead increases related to the new
manufacturing facility will increase by approximately $6,000 per
month as compared to the rent currently being paid by the
Company.

In 1996, the Company negotiated a $2,000,000 Industrial
Development Bond to finance a land acquisition and construction
of a new 51,000 square foot headquarters and manufacturing
facility.  On October 29, 1996, the Company completed a
transaction for the amount of $50,000 cash and 130,000 shares of
unregistered stock of the Company for the purchase of
approximately 3.7 acres of land within Murray City, Salt Lake
County, Utah, for the purpose of constructing a manufacturing
facility with an unrelated party.  The Company expects to spend
approximately $2,500,000 on the new manufacturing facility to be
completed in 1997.

The Company's working capital at March 31, 1997, was $4,859,698,
as compared to $2,471,632 at March 31, 1996.  Increase in working
capital is primarily due to the $2,000,000 industrial development
bond obtained by the company for financing the new manufacturing
facility, and the private placement agreement outlined below.
The portion of working capital represented by cash at such dates
was $2,225,531, and $850,677 respectively.  The Company utilizes
substantial portions of its cash from time to time to fund its
operations including increases in inventories, accounts
receivable and work in progress in connection with various
customer orders.

On December 16, 1996, the Company entered into a Private
Placement memorandum agreement to offer, on a best efforts basis,
$1,250,000 of its securities which consist of 500,000 units at a
price of $2.50 per unit.  Each unit consists of one share of
common stock and a warrant to purchase one share of common stock
at a price of $3.50 per share.  The offering was sold directly by
the Company through its officers and directors.  The offering
successfully closed on February 12, 1997.  The offering proceeds
will be used for general corporate purposes.

On  December  11, 1996, the Company entered into a $500,000  open
line  of  credit  arrangement with a financial institution.   The
line  is  due May 31, 1997.  The line of credit is collateralized
by  accounts receivable rights and bears interest at  a  rate  of
prime  plus  1%.  The Company owes $0 on the line  of  credit  at
March 31, 1997.
 .
                             PART II
          OTHER INFORMATION NOT APPLICABLE AT THIS TIME

Item 1.  Legal Proceedings
Item 2.  Changes in Securities
Item 3.  Defaults upon Senior Securities
Item 4.  Submission of Matters to a Vote of Security Holders
Item 5.  Other Information
Item 6.  Exhibits and Reports on Form 8-K



______________________________________________________________________

                           SIGNATURES
______________________________________________________________________

Pursuant to the requirements of the Securities Exchange Act of 1934,
as amended, the Registrant has duly caused this report to be signed on
its behalf by the undersigned thereunto duly authorized.


ZEVEX INTERNATIONAL, INC.


Dated:  May 12, 1997                  By   /s/ Dean G. Constantine
Dean G. Constantine, President


                                      By   /s/ Phillip L. Mcstotts
                                        Phillip L. McStotts, Secretary
                                         (Principal Financial Officer)